Bal Pharma Limited (BALPHARMA) — Capital Reinvestment Ratio

Latest as of September 2025: 1.07x

Bal Pharma Limited (BALPHARMA) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs101.16 Million) in capital expenditures (Rs107.94 Million). See BALPHARMA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.07x
Capex / Operating Cash Flow

Operating Cash Flow

Rs101.16 Million
INR

Capital Expenditures

Rs107.94 Million
INR

Data as of

Sep 2025
Most recent filing

Bal Pharma Limited Capital Reinvestment Ratio (2007–2026)

This chart tracks Bal Pharma Limited's Capital Reinvestment Ratio across 16 annual periods.

Annual Capital Reinvestment Ratio for Bal Pharma Limited (2007–2026)

Year-by-year Capital Reinvestment Ratio for Bal Pharma Limited from 2007 to 2026. For live market cap and broader valuation context, see Bal Pharma Limited (BALPHARMA) total market value.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2026 1.28x Rs144.72 Million Rs185.55 Million ▼ -71.1%
2025 4.44x Rs42.32 Million Rs187.87 Million ▲ +822.0%
2024 0.48x Rs228.06 Million Rs109.80 Million ▲ +57.5%
2022 0.31x Rs277.08 Million Rs84.69 Million ▲ +95.0%
2021 0.16x Rs217.81 Million Rs34.13 Million ▼ -28.5%
2020 0.22x Rs231.01 Million Rs50.63 Million ▼ -80.2%
2019 1.11x Rs77.58 Million Rs85.94 Million ▼ -22.6%
2017 1.43x Rs58.58 Million Rs83.82 Million ▲ +270.0%
2015 0.39x Rs145.33 Million Rs56.20 Million ▼ -31.0%
2014 0.56x Rs133.13 Million Rs74.61 Million ▲ +114.5%
2013 0.26x Rs163.39 Million Rs42.69 Million ▼ -7.5%
2012 0.28x Rs128.58 Million Rs36.34 Million ▼ -11.2%
2011 0.32x Rs46.09 Million Rs14.66 Million ▼ -64.6%
2009 0.90x Rs127.64 Million Rs114.64 Million ▼ -43.2%
2008 1.58x Rs90.75 Million Rs143.54 Million ▼ -22.0%
2007 2.03x Rs51.55 Million Rs104.51 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow